Validation of phospholipase A


Journal

Pathology
ISSN: 1465-3931
Titre abrégé: Pathology
Pays: England
ID NLM: 0175411

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 30 01 2020
revised: 30 03 2020
accepted: 06 04 2020
pubmed: 23 6 2020
medline: 4 6 2021
entrez: 23 6 2020
Statut: ppublish

Résumé

Distinguishing between primary and secondary subtypes of membranous glomerulonephritis (MGN) is critical for its clinical management. We prospectively compared direct immunofluorescence (DIF) staining for phospholipase A

Identifiants

pubmed: 32564921
pii: S0031-3025(20)30821-7
doi: 10.1016/j.pathol.2020.04.003
pii:
doi:

Substances chimiques

Autoantibodies 0
Receptors, Phospholipase A2 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

546-551

Informations de copyright

Copyright © 2020 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.

Auteurs

Pei Dai (P)

Department of Immunopathology, New South Wales Health Pathology-Institute of Clinical Pathology and Medical Research, Westmead Hospital, Sydney, NSW, Australia. Electronic address: pei.dai@gmail.com.

David Campbell (D)

Department of Immunopathology, New South Wales Health Pathology-Institute of Clinical Pathology and Medical Research, Westmead Hospital, Sydney, NSW, Australia.

Suzanne Culican (S)

Department of Immunopathology, New South Wales Health Pathology-Institute of Clinical Pathology and Medical Research, Westmead Hospital, Sydney, NSW, Australia.

David A Brown (DA)

Department of Immunopathology, New South Wales Health Pathology-Institute of Clinical Pathology and Medical Research, Westmead Hospital, Sydney, NSW, Australia; Centre for Allergy and Immunology Research, Westmead Institute, Sydney, NSW, Australia; Sydney Medical School, University of Sydney, Sydney, NSW, Australia.

Karen Byth (K)

Sydney Medical School, University of Sydney, Sydney, NSW, Australia; Research and Education Network, Westmead Hospital, Sydney, NSW, Australia.

Pravin Hissaria (P)

SA Pathology, Adelaide, SA, Australia.

Ruth Ninnes (R)

SA Pathology, Adelaide, SA, Australia.

Brian Nankivell (B)

Department of Renal Medicine, Westmead Hospital, Sydney, NSW, Australia.

Ming-Wei Lin (MW)

Department of Immunopathology, New South Wales Health Pathology-Institute of Clinical Pathology and Medical Research, Westmead Hospital, Sydney, NSW, Australia; Centre for Allergy and Immunology Research, Westmead Institute, Sydney, NSW, Australia; Sydney Medical School, University of Sydney, Sydney, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH